Abstract
Advances in patient care and immunosuppressive drugs have improved graft survival, resulting in an increase in kidney transplantation (KT); however, persistent immunosuppression is thought to cause late occurrence of cancer. This population-based study consisted of a total of 14,842 patients whose data from the years 2002 to 2017 were collected from the National Health Information Database in South Korea. Malignancies occurred in 7.6% of the total KT patients. Prostate and thyroid cancers were the most common in males and females, respectively. From the age-adjusted incidence analysis, Kaposi’s sarcoma showed the highest standardized incidence ratio in both male and female patients. According to the linear regression model, cancer incidence in KT recipients under immunosuppressive conditions increased by approximately 0.1% each month. Patients’ age over 39 and the use of prednisolone as an initial steroid regimen were associated with increased risk of cancer development after KT. Our regression and proportional hazards models will help clinicians to predict the approximate cancer incidence risk when monitoring KT recipients. Based on the largest available national database, screening or monitoring methods for cancer detection and prevention can be established for KT patients by considering the factors involved in cancer development.
Original language | English |
---|---|
Article number | 3530 |
Journal | Journal of Clinical Medicine |
Volume | 10 |
Issue number | 16 |
DOIs | |
Publication status | Published - 2021 Aug 2 |
Bibliographical note
Funding Information:Funding: This research was funded by a grant from the National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea (Study no. 2019–20-002 and data no. REQ0000029925).
Funding Information:
This research was funded by a grant from the National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea (Study no. 2019?20-002 and data no. REQ0000029925). This study used the NHIS-NHID as its data source (no. REQ0000029925). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Health Insurance Service, Ilsan Hospital, Goyang, Republic of Korea.
Publisher Copyright:
© 2021 by the author. Licensee MDPI, Basel, Switzerland.
All Science Journal Classification (ASJC) codes
- Medicine(all)